Prevention of Severe SARS-CoV-2 Infection in Hospitalized Patients With COVID-19
Clinical trial NCT04530136 · COMPLETED
Trial details
- NCT number
- NCT04530136
- Sponsor
- Pharming Technologies B.V.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-11-30
- Primary completion
- 2021-09-07
- Enrollment
- 38
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.